Durable response in a patient with recurrent respiratory papillomatosis treated with immune checkpoint blockade.

Although demonstrated in a single exceptional responder, these results highlight that immune checkpoint blockade may induce durable, viral antigen-specific immunity of sufficient magnitude to control disease in patients with nonmalignant disorders.